Trial Details

COMPLETED
Basic Information
Clinical ID c2963
Identifier NCT02727751
Trial Title A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Constipation Predominant Irritable Bowel Syndrome
Interventions DRUG: Tenapanor
Participant Information
Sponsor Ardelyx
City Miami
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2016-03
Primary Completion Date 2017-10
Completion Date 2017-10